Mesalamine
- Product NDC
- 0591-2245
- 11-digit product format
- 005912245
- Labeler code
- 0591
- Product ID
- 0591-2245_1300887a-c110-46b3-a8be-cfceabf0cbf2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mesalamine
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA203817
- Marketing category
- ANDA
- Marketing start
- 2018-03-26
- Substance
- MESALAMINE
- Active strength
- 1.2 g/1
- Pharmacologic classes
- Aminosalicylate [EPC], Aminosalicylic Acids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mesalamine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MESALAMINE | 1.2 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4Q81I59GXC |
| Rxcui | 686429 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0591-2245-22 | Mesalamine | 120 in 1 BOTTLE | TABLET, DELAYED RELEASE | 120 | | 25 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0591-2245 | MESALAMINE TABLET, DELAYED RELEASE [ACTAVIS PHARMA, INC.] | 24 | Current NDC, Legacy NDC, 1 package rows | 20250416_ba1e3bd4-fbe0-46a5-961e-167ccb09672c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-2245-22 | 00591224522 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2245-22) | 2018-03-26 | 0000-00-00 | No | No | Current |